GSK | ||
---|---|---|
OUTLOOK RATING 1..100 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 8 Undervalued | |
PROFIT vs RISK RATING 1..100 | 49 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 44 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
FLGB | GSK | |
---|---|---|
RSI ODDS (%) | N/A | 2 days ago50% |
Stochastic ODDS (%) | 2 days ago78% | 2 days ago55% |
Momentum ODDS (%) | 2 days ago72% | 2 days ago74% |
MACD ODDS (%) | 2 days ago77% | 2 days ago41% |
TrendWeek ODDS (%) | 2 days ago83% | 2 days ago61% |
TrendMonth ODDS (%) | 2 days ago81% | 2 days ago54% |
Advances ODDS (%) | 5 days ago83% | 5 days ago59% |
Declines ODDS (%) | 9 days ago74% | 3 days ago51% |
BollingerBands ODDS (%) | 2 days ago81% | 2 days ago43% |
Aroon ODDS (%) | 2 days ago78% | 2 days ago46% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NAIL | 64.90 | 1.26 | +1.98% |
Direxion Daily Hmbldrs&Supls Bull 3X ETF | |||
MAYU | 30.87 | 0.14 | +0.45% |
AllianzIM US Equity Buffer15 Unc May ETF | |||
DFAT | 56.82 | 0.20 | +0.35% |
Dimensional US Targeted Value ETF | |||
TJUL | 29.37 | 0.05 | +0.17% |
Innovator Eq Defnd Protd ETF2 Yr-Jul2027 | |||
SAA | 24.98 | -0.06 | -0.24% |
ProShares Ultra SmallCap600 |
A.I.dvisor indicates that over the last year, FLGB has been loosely correlated with EVR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if FLGB jumps, then EVR could also see price increases.
Ticker / NAME | Correlation To FLGB | 1D Price Change % | ||
---|---|---|---|---|
FLGB | 100% | -0.06% | ||
EVR - FLGB | 47% Loosely correlated | -0.27% | ||
WIX - FLGB | 31% Poorly correlated | -1.22% | ||
NG - FLGB | 30% Poorly correlated | -8.17% | ||
RIO - FLGB | 30% Poorly correlated | -1.06% | ||
GSK - FLGB | 27% Poorly correlated | +0.32% | ||
More |
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.